{"id":13848,"date":"2021-04-08T14:12:49","date_gmt":"2021-04-08T14:12:49","guid":{"rendered":"https:\/\/interhospi.com\/?p=13848"},"modified":"2021-04-08T14:12:49","modified_gmt":"2021-04-08T14:12:49","slug":"horiba-medical-receives-ce-mark-for-new-generation-microsemi-crp-haematology-analyser","status":"publish","type":"post","link":"https:\/\/interhospi.com\/horiba-medical-receives-ce-mark-for-new-generation-microsemi-crp-haematology-analyser\/","title":{"rendered":"HORIBA Medical receives CE Mark for new generation Microsemi CRP haematology analyser"},"content":{"rendered":"

\"HoribaHORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the\u00a0Microsemi CRP LC-767G.<\/p>\n

This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new parameter: Granulocytes-to-Lymphocytes Ratio (GLR). The incredible robustness and ease of use of the Micros range are further improved for this new generation analyser.<\/p>\n

Developed by HORIBA Medical in Japan, \u2018emi\u2019 means \u2018smile\u2019 in Japanese and stands for easy to use, maintenance free and Intelligent. After a highly successful release in Japan, this unique instrument is now available in Europe. This compact, easy to use addition to the Micros range, simultaneously provides a Complete Blood Count (CBC) and C-Reactive Protein (CRP) from just 18 \u00b5L of blood \u2013 all in just 4 minutes.<\/p>\n

Point of Care<\/h3>\n

The Microsemi CRP LC-767G provides information of great clinical value enabling quicker and more accurate medical decisions at the Point of Care\u00a0to ultimately reduce hospitalization times and patient costs. Its powerful and accurate CRP analysis allows the screening of patient samples to quantify the presence of inflammation caused by bacterial, viral (e.g. Covid-19), parasitic infections (e.g. malaria) and other treatable inflammatory diseases.<\/p>\n

The simultaneous access to Lymphocytes, GLR and CRP provided on this analyser is helpful for Covid-19 patient screening, monitoring and triage. Measurement is possible immediately after blood sample collection from capillary sample, making this analyser the ideal choice for emergency testing situations.<\/p>\n

This new Microsemi CRP LC-767G can also be used to assess infection and inflammatory conditions that require progressive observation. Furthermore, its\u00a0micro-sampling capabilities\u00a0are ideal for paediatric blood analysis, at the\u00a0Point of Care\u00a0requiring just 10\u00b5L for CBC and 18 \u00b5L for CBC+CRP, and can be used with capillary, as well as venous blood samples.<\/p>\n

The Microsemi CRP is easy to use and does not require specialist staff. Comprehensive and efficient on-board software with colour touchscreen and easy to access patient and control results are features of the Microsemi CRP. It is compact, lightweight and quiet.<\/p>\n